Simón Méndez-Ferrer

23PUBLICATIONS
77CO-AUTHORS
Haematological tumoursMedical infection agents (incl. prions)Predictive and prognostic markersInnate immunitySocio-economic development
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|May 15, 2025
Defective neutrophil clearance in JAK2V617F myeloproliferative neoplasms drives myelofibrosis via immune checkpoint CD24.

Eman Khatib-Massalha, Christian A Di Buduo, Agathe L Chédeville

|Jan 11, 2024
IL-1β promotes MPN disease initiation by favoring early clonal expansion of JAK2-mutant hematopoietic stem cells.

Shivam Rai, Yang Zhang, Elodie Grockowiak

|Nov 24, 2023
Tamoxifen for the treatment of myeloproliferative neoplasms: A Phase II clinical trial and exploratory analysis.

Zijian Fang, Giuditta Corbizi Fattori, Thomas McKerrell

|Sep 01, 2023
The Inflamed Niche: A Double-Edged Sword in AML?

Livia E Lisi-Vega, Simón Méndez-Ferrer

|Aug 07, 2023
Different niches for stem cells carrying the same oncogenic driver affect pathogenesis and therapy response in myeloproliferative neoplasms.

Elodie Grockowiak, Claudia Korn, Justyna Rak

|Jul 28, 2022
Mesoderm-derived PDGFRA+ cells regulate the emergence of hematopoietic stem cells in the dorsal aorta.

Vashe Chandrakanthan, Prunella Rorimpandey, Fabio Zanini

Pageof 4

Frequent Collaborators

2 joint publications

Livia E Lisi-Vega

2 joint publications

Berthold Göttgens

2 joint publications

Andrés García-García

1 joint publications

Angela G Fleischman